Relative dose and vascular response after drug-eluting stent implantation: A dosimetric 3D-intravascular ultrasound study.

Abstract

BACKGROUND:

In drug-eluting stents (DESs), the theoretical drug dose exposed to the vessel wall per stent surface area may vary due to the fixed loading dose and differences in the stent surface area once expanded in varying vessel sizes. The aim of this study was to evaluate the potential effects of different dose intensities, as estimated by 3D-IVUS dosimetry, on vascular response after DES implantation.

METHODS:

Follow-up (6-9 months) 3D-IVUS was performed in 840 coronary lesions treated with a single DES of the following types: sirolimus (SES, n=148), paclitaxel (PES, n=162), Endeavor zotarolimus (E-ZES, n=233), Resolute zotarolimus (R-ZES, n=147), and everolimus (EES, n=150). Volume index (volume/length, mm(3)/mm) was obtained for vessel, lumen, plaque, stent, and neointima. In each lesion, exposed dose intensity was calculated as known loading dose divided by measured luminal surface area of the stented segment. Lesions were divided into tertiles based on the exposed dose intensity: high, medium, and low dose groups.

RESULTS:

The exposed dose intensity ranged 0.74-1.76 μg/mm(2) for SES, 0.41-1.18 μg/mm(2) for PES, 0.71-1.57 μg/mm(2) for E-ZES, 0.72-1.63 μg/mm(2) for R-ZES, and 0.40-0.99 μg/mm(2) for EES. All types of DES showed no significant difference in neointimal hyperplasia among the 3 groups, except that E-ZES showed significantly less neointimal hyperplasia in the high dose group.

CONCLUSIONS:

Detailed 3D-IVUS revealed significant lesion-to-lesion variability in dose intensity exposed to the vessel wall following DES implantation. However, the major types of DES appear to yield equally effective neointimal suppression, despite the varying dose intensity, except for E-ZES.

• Authors: Hideki Kitahara, Katsuhisa Waseda, Ryotaro Yamada, Kenji Sakamoto, Paul G Yock, Peter J Fitzgerald, Yasuhiro Honda
• Journal: International journal of cardiology (Int J Cardiol) Vol. 204 Pg. 211-7 (Feb 01 2016) ISSN: 1874-1754 [Electronic] Netherlands
• PMID: 26681540 (Publication Type: Journal Article)
• Copyright: Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Topics

• Aged
• Coronary Artery Disease (diagnostic imaging, therapy)
• Dose-Response Relationship, Drug
• Drug-Eluting Stents
• Female
• Follow-Up Studies
• Humans
• Imaging, Three-Dimensional (methods)
• Male
• Middle Aged
• Retrospective Studies
• Treatment Outcome
• Ultrasonography, Interventional (methods)